Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon acquired 14 shares of Johnson Matthey stock in a transaction that occurred on Friday, July 10th. The shares were purchased at an average price of GBX 1,909 per share, for a total transaction of £267.26.
Liam Condon also recently made the following trade(s):
- On Wednesday, June 10th, Liam Condon bought 12 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 1,990 per share, with a total value of £238.80.
- On Monday, June 1st, Liam Condon purchased 4,500 shares of Johnson Matthey stock. The stock was acquired at an average price of GBX 2,127 per share, for a total transaction of £95,715.
- On Wednesday, April 15th, Liam Condon bought 12 shares of Johnson Matthey stock. The shares were bought at an average cost of GBX 2,022 per share, with a total value of £242.64.
Johnson Matthey Stock Performance
Shares of JMAT stock traded up GBX 29.29 during trading hours on Monday, reaching GBX 1,924. The stock had a trading volume of 362,535 shares, compared to its average volume of 2,669,878. The firm has a 50-day simple moving average of GBX 2,076.73 and a 200-day simple moving average of GBX 2,105.16. The firm has a market capitalization of £3.23 billion, a PE ratio of -33.64, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.94. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. Johnson Matthey PLC has a twelve month low of GBX 1,730.72 and a twelve month high of GBX 2,434.
Analysts Set New Price Targets
JMAT has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 2,400 price target on shares of Johnson Matthey in a report on Monday, July 6th. Jefferies Financial Group restated a “restricted” rating on shares of Johnson Matthey in a report on Friday, May 29th. Berenberg Bank increased their price objective on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research note on Monday, June 1st. Finally, UBS Group reiterated a “neutral” rating and set a GBX 2,200 target price on shares of Johnson Matthey in a research report on Friday, May 22nd. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Johnson Matthey currently has an average rating of “Moderate Buy” and an average target price of GBX 2,298.33.
Get Our Latest Stock Analysis on Johnson Matthey
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- Why Micron Is Doubling Down While the HBM Shortage Persists
- China’s Helium Ban Could Reshape the AI Supply Chain
- Analysts See Major Upside for These 5 Stocks
- AMD’s 5C Deal Positions It as a Direct NVIDIA Rival
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
